SBS ASSOCIATED WITH INTESTINAL FAILURE (SBS-IF)

Clinical trials for SBS ASSOCIATED WITH INTESTINAL FAILURE (SBS-IF) explained in plain language.

Never miss a new study

Get alerted when new SBS ASSOCIATED WITH INTESTINAL FAILURE (SBS-IF) trials appear

Sign up with your email to follow new studies for SBS ASSOCIATED WITH INTESTINAL FAILURE (SBS-IF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a weekly injection ease the burden of short bowel syndrome?

Disease control Recruiting now

This phase 3 trial is testing whether apraglutide, a synthetic version of a natural gut hormone, can help adults with short bowel syndrome and intestinal failure reduce their need for intravenous nutrition (parenteral support). Participants receive either apraglutide or a placebo…

Matched conditions: SBS ASSOCIATED WITH INTESTINAL FAILURE (SBS-IF)

Phase: PHASE3 • Sponsor: VectivBio AG • Aim: Disease control

Last updated Aug 06, 2026 00:00 UTC

SBS ASSOCIATED WITH INTESTINAL FAILURE (SBS-IF)

Get alerted when new SBS ASSOCIATED WITH INTESTINAL FAILURE (SBS-IF) trials appear

Can a weekly injection ease the burden of short bowel syndrome?